AN2 Therapeutics, Inc.ANTXNASDAQ
Loading
Shares Out (Diluted) Over TimeStrong
Percentile Rank100
3Y CAGR+25.4%
5Y CAGR+10.0%
Studio
Year-over-Year Change

Weighted average diluted shares outstanding

3Y CAGR
+25.4%/yr
Annual compound
5Y CAGR
+10.0%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
3 yr
Consecutive growthStrong
PeriodValueYoY Change
202530215747.00+1.3%
202429828000.00+26.4%
202323600000.00+53.8%
202215340000.00-18.1%
202118740000.000.0%
202018740000.000.0%
201918740000.00-